| Intellectual Property Specializing works Coburn has success with sequence listing |
| Amgen Wins Summary Judgement Against Genetics Insitute In Ongoing Erythropoietin Litigation |
| An Overview of the PTO Sequence Rules (37 CFR §§1.821-1.825) |
| EST's and Partial Sequences: Repercussions for the Biotech Client |
| Getting PAST BLAST and FAST(A) |
| Greater Predictability May Result in Patent Pools |
| Ajinomoto Sues ADM Over Amino Acid Patent |
| PTO Hearings on Patenting of Nucleic Acid Sequences Highlight Higher Costs and Other Examination Problems |
| Round Three: Amgen Strikes Back by Suing Genetics Institute to Enforce Earlier Settlement Agreement |
| Sequence Rule Compliance: Separating the Wizards from the Muggles |
| The Genesis of USGENE |
| Patent Challenges for Therapeutic RNAi - Presented Nov. 4 2010 (Boston, MA) |
| The Past, Present and Future of Sequence Listing Preparation |
| The Past, Present and Future of Sequence Listing Preparation (Part II) |